TABLE 3.
The application of exosomes and EVs in stroke clinical trials.
| ClinicalTrials.gov identifier | Official tittle | Study type | First posted | Estimated/Actual study start date | Condition or disease | Intervention/Treatement |
|---|---|---|---|---|---|---|
| NCT05326724 | The Role of Acupuncture-induced Exosome in Treating Post-stroke Dementia | Interventional (clinical trial) | 13 April 2022 | 1 August 2022 | Exosome | Device: Acupuncture |
| Post-stroke Dementia | ||||||
| Acupuncture | ||||||
| NCT03384433 | Allogenic Mesenchymal Stem Cell Derived Exosome in Patients with Acute Ischemic Stroke | Interventional (clinical trial) | 27 December 2017 | 17 April 2019 | Cerebrovascular disorders | Biological: exosome |
| NCT05370105 | Extracellular Vesicles as Stroke Biomarkers (EXO4STROKE) | Observational | 11 May 2022 | 25 June 2018 | Stroke Rehabilitation | Other: blood withdrawal |
| NCT05524506 | PROgnostic Value of MicroParticles and Markers of Hemostasis in TIA and Ischemic Stroke (PROMPTS) | Observational | 1 September 2022 | June 2007 | Brain Ischemia | - |
| Cerebral Ischemia | ||||||
| Extracellular Vesicles | ||||||
| Hemostasis | ||||||
| Prognosis |